EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma

Radhika Manukonda, Saumya Jakati, Jyothi Attem, Dilip K Mishra, Tirupathi Rao Mocherla, Mamatha M Reddy, Khushboo Gulati, Krishna Mohan Poluri, Geeta K Vemuganti, Swathi Kaliki

Investigative Opthalmology & Visual Science · 2023-08-21 · 64 (11) · 26

DOI: 10.1167/iovs.64.11.26 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, published on 2023-08-21. Written by Radhika Manukonda and 9 co-authors. Institution: The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India. Major MEDLINE topics: Retinoblastoma, Extracellular Vesicles, Retinal Neoplasms. Cited 10 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Purpose

To identify the genes and pathways responsible for treatment resistance (TR) in retinoblastoma (RB) by analyzing serum small extracellular vesicles (sEVs) of patients with TR active RB (TR-RB) and completely regressed RB (CR-RB).

Methods

Serum-derived sEVs were characterized by transmission electron microscopy and nanoparticle tracking analysis. sEV transcriptome profiles of two TR-RB and one CR-RB with good response (>20 years tumor free) were compared to their age-matched controls (n = 3). Gene expression data were analyzed by the R Bioconductor package. The CD9 protein and mRNA expression of CD9, CD63, and CD81 were studied in five RB tumors and two control retinae by immunohistochemistry and quantitative reverse transcription-polymerase chain reaction.

Results

The isolated serum sEVs were round shaped and within the expected size (30-150 nm), and they had zeta potentials ranging from -10.8 to 15.9 mV. The mean ± SD concentrations of sEVs for two adults and four children were 1.1 × 1012 ± 0.1 and 5.8 × 1011 ± 1.7 particles/mL. Based on log2 fold change of ±2 and P < 0.05 criteria, there were 492 dysregulated genes in TR-RB and 184 in CR-RB. KAT2B, VWA1, CX3CL1, MLYCD, NR2F2, USP46-AS1, miR6724-4, and LINC01257 genes were specifically dysregulated in TR-RB. Negative regulation of apoptotic signaling, cell growth, and proton transport genes were greater than fivefold expressed only in TR-RB. CD9, CD63, and CD81 mRNA levels were high in RB tumors versus control retina, with increased and variable CD9 immunoreactivity in the invasive areas of the tumor.

Conclusions

Serum sEVs could serve as a potential liquid biopsy source for understanding TR mechanisms in RB.

Subjects

MeSH terms (MEDLINE)

RetinoblastomaExtracellular VesiclesRetinal NeoplasmsAdultChildHumansRetinaSignal Transduction

Authors and institutions

  • The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India.
  • Brien Holden Eye Research Center, L V Prasad Eye Institute, Hyderabad, Telangana, India.
  • Ophthalmic Pathology Laboratory, L V Prasad Eye Institute, Hyderabad, Telangana, India.
  • Prof. Krothapalli Ravindranath Ophthalmic Research Biorepository, L V Prasad Eye Institute, Hyderabad, Telangana, India.
  • School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad, Telangana, India.
  • The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar, Odisha, India.

Cite

APA

Manukonda, R., Jakati, S., Attem, J., Mishra, D. K., Mocherla, T. R., Reddy, M. M., Gulati, K., Poluri, K. M., Vemuganti, G. K., & Kaliki, S. (2023). Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma. Investigative Opthalmology & Visual Science, 64(11), 26. https://doi.org/10.1167/iovs.64.11.26

Vancouver

Manukonda R, Jakati S, Attem J, Mishra DK, Mocherla TR, Reddy MM, et al. Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma. Investigative Opthalmology & Visual Science. 2023;64(11):26. doi:10.1167/iovs.64.11.26

BibTeX
@article{Manukonda2023,
  author = {Manukonda, Radhika and Jakati, Saumya and Attem, Jyothi and Mishra, Dilip K and Mocherla, Tirupathi Rao and Reddy, Mamatha M and Gulati, Khushboo and Poluri, Krishna Mohan and Vemuganti, Geeta K and Kaliki, Swathi},
  title = {Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  volume = {64},
  number = {11},
  pages = {26},
  doi = {10.1167/iovs.64.11.26}
}
Start for free →